CRONOS GROUP INC. Operating Income
CRONOS GROUP INC. (CRON) reported Operating Income of $7.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- CRONOS GROUP INC. operating income (loss) for the quarter ending 2026-06-30 was $7.40M.
- CRONOS GROUP INC. operating income (loss) for the quarter ending 2026-03-31 was -$1.83M.
- CRONOS GROUP INC. operating income (loss) for the quarter ending 2025-12-31 was -$7.50M.
- CRONOS GROUP INC. operating income (loss) for the quarter ending 2025-09-30 was -$503.00K.
- CRONOS GROUP INC. operating income (loss) for fiscal 2025 was -$17.39M.
- CRONOS GROUP INC. operating income (loss) for fiscal 2024 was -$76.53M.
- CRONOS GROUP INC. operating income (loss) for fiscal 2023 was -$84.80M.
- CRONOS GROUP INC. operating income (loss) for fiscal 2022 was -$111.43M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.40M 10-Q · filed 2026-08-06 | $5.57M 10-Q · filed 2026-08-06 | -$1.93M derived: sum of 3 quarters · filed 2026-08-06 | -$2.43M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$1.83M 10-Q · filed 2026-05-11 | -$9.33M derived: sum of 2 quarters · filed 2026-05-11 | -$9.83M derived: sum of 3 quarters · filed 2026-05-11 | -$15.16M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$8.00M derived: sum of 2 quarters · filed 2026-02-26 | -$13.32M derived: sum of 3 quarters · filed 2026-08-06 | -$17.39M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$503.00K 10-Q · filed 2025-11-06 | -$5.83M derived: sum of 2 quarters · filed 2026-08-06 | -$9.90M 10-Q · filed 2025-11-06 | -$21.26M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$5.32M 10-Q · filed 2026-08-06 | -$9.40M 10-Q · filed 2026-08-06 | -$20.76M derived: sum of 3 quarters · filed 2026-08-06 | -$54.42M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$4.07M 10-Q · filed 2026-05-11 | -$15.44M derived: sum of 2 quarters · filed 2026-05-11 | -$49.09M derived: sum of 3 quarters · filed 2026-05-11 | -$64.65M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | -$11.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$45.02M derived: sum of 2 quarters · filed 2026-02-26 | -$60.58M derived: sum of 3 quarters · filed 2026-02-26 | -$76.53M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$33.66M 10-Q · filed 2025-11-06 | -$49.22M derived: sum of 2 quarters · filed 2025-11-06 | -$65.16M 10-Q · filed 2025-11-06 | -$86.80M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | -$15.56M 10-Q · filed 2025-08-07 | -$31.51M 10-Q · filed 2025-08-07 | -$53.15M derived: sum of 3 quarters · filed 2026-02-26 | -$74.92M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$15.95M 10-Q · filed 2025-05-08 | -$37.58M derived: sum of 2 quarters · filed 2026-02-26 | -$59.36M derived: sum of 3 quarters · filed 2026-02-26 | -$79.98M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$21.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$43.41M derived: sum of 2 quarters · filed 2026-02-26 | -$64.03M derived: sum of 3 quarters · filed 2026-02-26 | -$84.80M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | -$21.77M 10-Q · filed 2024-11-12 | -$42.40M derived: sum of 2 quarters · filed 2024-11-12 | -$63.16M 10-Q · filed 2024-11-12 | -$90.20M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | -$20.62M 10-Q · filed 2024-08-08 | -$41.39M 10-Q · filed 2024-08-08 | -$68.42M derived: sum of 3 quarters · filed 2025-02-27 | -$95.75M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | -$20.77M 10-Q · filed 2024-05-09 | -$22.00M 10-Q · filed 2023-05-09 | -$47.80M derived: sum of 2 quarters · filed 2025-02-27 | -$75.14M derived: sum of 3 quarters · filed 2025-02-27 | -$100.44M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | -$27.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$54.37M derived: sum of 2 quarters · filed 2025-02-27 | -$79.67M derived: sum of 3 quarters · filed 2025-02-27 | -$111.43M 10-K · filed 2025-02-27 | -$124.84M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | -$27.33M 10-Q · filed 2023-11-08 | -$31.00M 10-Q · filed 2022-11-07 | -$52.64M derived: sum of 2 quarters · filed 2023-11-08 | -$84.40M 10-Q · filed 2023-11-08 | -$95.12M 10-Q · filed 2022-11-07 | $17.30M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | -$25.30M 10-Q · filed 2023-08-08 | -$28.07M 10-Q · filed 2022-08-09 | -$57.06M 10-Q · filed 2023-08-08 | -$64.11M 10-Q · filed 2022-08-09 | $44.64M derived: sum of 3 quarters · filed 2024-02-29 | -$11.78M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | -$36.05M 10-Q · filed 2023-05-09 | $69.94M derived: sum of 2 quarters · filed 2024-02-29 | $13.53M derived: sum of 3 quarters · filed 2024-02-29 | -$282.82M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $105.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $49.58M derived: sum of 2 quarters · filed 2024-02-29 | -$246.77M derived: sum of 3 quarters · filed 2024-02-29 | -$291.97M 10-K · filed 2024-02-29 | -$560.59M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | -$56.41M 10-Q · filed 2022-11-07 | -$352.76M derived: sum of 2 quarters · filed 2022-11-07 | -$397.96M 10-Q · filed 2022-11-07 | -$456.41M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | -$296.35M 10-Q · filed 2022-08-09 | -$60.22M 10-Q · filed 2021-08-06 | -$341.55M 10-Q · filed 2022-08-09 | -$103.68M 10-Q · filed 2021-08-06 | -$400.00M derived: sum of 3 quarters · filed 2023-02-28 | -$441.16M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | -$45.20M 10-Q · filed 2022-05-10 | -$43.46M 10-Q · filed 2021-05-07 | -$103.65M derived: sum of 2 quarters · filed 2023-02-28 | -$144.82M derived: sum of 3 quarters · filed 2023-02-28 | -$219.53M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | -$58.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$99.62M derived: sum of 2 quarters · filed 2023-02-28 | -$174.33M derived: sum of 3 quarters · filed 2023-02-28 | -$219.39M 10-K · filed 2023-02-28 | -$179.35M 10-K · filed 2021-02-26 | |||
| 2020-09-30 | -$41.17M 10-Q · filed 2022-02-18 | -$115.88M derived: sum of 2 quarters · filed 2022-02-18 | -$160.94M 10-Q · filed 2022-02-18 | -$120.94M 10-Q · filed 2020-11-05 | -$256.71M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | -$74.71M 10-Q/A · filed 2022-02-18 | -$34.76M 10-Q · filed 2020-08-06 | -$119.77M 10-Q/A · filed 2022-02-18 | -$79.81M 10-Q · filed 2020-08-06 | -$215.54M derived: sum of 3 quarters · filed 2022-03-01 | -$246.24M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | -$45.06M 10-Q · filed 2021-05-07 | -$140.84M derived: sum of 2 quarters · filed 2022-03-01 | -$171.53M derived: sum of 3 quarters · filed 2022-03-01 | -$188.29M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | -$95.78M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$126.47M derived: sum of 2 quarters · filed 2022-03-01 | -$143.23M derived: sum of 3 quarters · filed 2022-03-01 | -$153.32M 10-K · filed 2022-03-01 | -$121.48M 10-K/A · filed 2020-03-30 | |||
| 2019-09-30 | -$30.70M 10-Q · filed 2020-11-05 | -$47.45M derived: sum of 2 quarters · filed 2020-11-05 | -$57.54M 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | -$16.75M 10-Q · filed 2020-08-06 | -$26.88M 10-Q · filed 2020-08-06 | ||||||
| 2019-03-31 | -$10.13M 10-Q · filed 2020-05-08 | |||||||
| 2018-12-31 | -$20.45M 10-K · filed 2021-02-26 | -$21.34M 10-K/A · filed 2020-03-30 | ||||||
| 2017-12-31 | -$6.12M 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |